| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Salidroside | Breast Cancer | 2 | PM | 37358272 | 📋 | Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration |
| Salidroside | Breast Cancer | 1 | PM | 34978808 | 📋 | Salidroside Promotes Sensitization to Doxorubicin in Human Cancer Cells by Affecting the PI3K/Akt/HIF Signal Pathway and Inhibiting the Expression of Tumor-Resistance-Related Proteins |
| Salidroside | Breast Cancer | 5 | PM | 33238796 | 📋 | Inhibitory effects of salidroside on MCF-7 breast cancer cells in vivo |
| Salidroside | Breast Cancer | 4 | PM | 25814002 | 📋 | Salidroside inhibits the growth of human breast cancer in vitro and in vivo |
| Salidroside | Breast Cancer | 3 | PM | 20541529 | 📋 | Salidroside induces cell-cycle arrest and apoptosis in human breast cancer cells |
| Salidroside | Endometrial Cancer | 1 | PM | 37644107 | 📋 | Mechanism of salidroside in the treatment of endometrial cancer based on network pharmacology and molecular docking |
| Salidroside | Gestational Hypertension | 1 | PM | 38641312 | 📋 | Salidroside prevents gestational hypertension-induced impairment of offspring learning and memory via Wnt/Skp2 pathway |
| Salidroside | Mastitis | 1 | PM | 22915087 | 📋 | Salidroside attenuates inflammatory responses by suppressing nuclear factor-κB and mitogen activated protein kinases activation in lipopolysaccharide-induced mastitis in mice |
| Salidroside | Polycystic Ovary Syndrome | 1 | PM | 34813774 | 📋 | Salidroside alleviates oxidative stress and apoptosis via AMPK/Nrf2 pathway in DHT-induced human granulosa cell line KGN |
